Nanosyn, provider of Discovery on Demand services, is a medicinal chemistry and biological services contract research organization providing made-to-order focused compound libraries, hit-to-lead optimization, medicinal chemistry services and other innovative solutions to meet your drug discovery needs.
Our proprietary technology allows us to provide superior chemistry and biology services that effectively accelerate the drug discovery process for biotechnology and pharmaceutical companies worldwide. We use advanced microfluidics screening platform from Caliper LifeSciences to perform high-throughput screening and profiling.
May 30th, 2017 - NeurAegis has chosen Nanosyn to lead its chemistry efforts towards advancing novel and selective calpain-2 inhibitors to clinical candidates. Click here for more information.
February 8th, 2017 - Nanosyn announced today a continuation of collaboration in the Epigenetic Research Initiative with the Mayo Clinic. Click here for more information.
October 26th, 2015 - Nanosyn announces an important publication in the November issue of Nature Biotechnology. Click here for more information.
May 22nd, 2015 - GlaxoSmithKline's presentation from the 2nd RSC Symposium on Chemical Biology for Drug Discovery highlights Nanosyn's capacity for vital research, accuracy, and the delivery of high quality data. Click here for more information.